Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06167239
Other study ID # P.T.REC/012/004784
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 2, 2023
Est. completion date May 2024

Study information

Verified date April 2024
Source Cairo University
Contact Elmasry
Phone 01005587119
Email egydodo@rocketmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the current study is to compare the effect of ventilator trigger sensitivity adjustment versus threshold inspiratory muscle training on arterial blood gases in mechanically ventilated patients.


Description:

Failed extubations are not uncommon in most ICUs, the failure rate ranging from 2 to 20%. Since failed extubation is associated with greater hospital morbidity and mortality and longer length of stay, it is imperative to identify screening techniques that minimize the number of failed extubations. Many studies have been done on the effect of IMT by threshold IMT and adjustment of mechanical ventilator trigger separately, thereby, it is rational to compare between two methods of training to know which is more effective to help in weaning process through its effect on ABGs.


Recruitment information / eligibility

Status Recruiting
Enrollment 45
Est. completion date May 2024
Est. primary completion date May 2024
Accepts healthy volunteers No
Gender All
Age group 20 Years to 55 Years
Eligibility Inclusion Criteria: 1. Difficult to wean Guillain barre patients who have been on MV for at least 48 hours. Difficult to wean subjects have been defined as those who fail the first spontaneous breathing trial (SBT)and may require up to 3 SBTs or up to 7 d from the first attempt to achieve successful weaning (BĀ“eduneau G. et al.,2017) and (Annia F. et al.,2019). 2. Age: >18 years. 3. Both sexes will be included. 4. Ventilator mode: Pressure support mode with FiO2= 0.5, positive end expiratory pressure (PEEP) will be<8-10cm/H2Oand respiratory rate < 25. 5. Conscious oriented patient with Glasgow coma score =13. 6. Alertness will be titrated to a Riker Sedation Agitation Score of 4. 7. PH>7.25, arterial oxygen saturation >90%. 8. Cardiovascular stability. 9. Maximal inspiratory pressure from 15 to 30 cm H2O and able to trigger spontaneous breaths on ventilator. Exclusion Criteria: 1. Persistent hemodynamic instability as life threatening arrhythmias, acute heart failure. 2. Severe breathlessness, when spontaneously breathing. 3. Any progressive neuromuscular disease that would interfere with responding to inspiratory muscle training (non-stationary course). 4. Spinal cord injury. 5. Skeletal pathology (scoliosis, flail chest, spinal instrumentation) that would seriously impair the movement of the chest wall and ribs. 6. Patients on heavy sedation and respiratory muscle paralysis. 7. High peak airway pressure (barotraumas). 8. BMI = 40.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Threshold inspiratory muscle trainer or ventilator pressure setting inspiratory muscle training techniques
New techniques to train inspiratory muscles in mechanically ventilated patients

Locations

Country Name City State
Egypt Kasr Al Ainy School of Medicine Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary PH To measure PH Pre intervention and immediate post intervention, through study completion, an average of two weeks
Primary PaO2 To measure partial pressure of oxygen Pre intervention and immediate post intervention, through study completion, an average of two weeks
Primary PaCO2 To measure partial pressure of carbon dioxide Pre intervention and immediate post intervention, through study completion, an average of two weeks
Primary HCO3 To measure bicarbonate Pre intervention and immediate post intervention, through study completion, an average of two weeks
Secondary Rapid shallow breathing index To measure respiratory endurance Pre intervention and immediate post intervention, through study completion, an average of two weeks
Secondary The Horowitz index To measure PaO2 /FiO2 ratio Pre intervention and immediate post intervention, through study completion, an average of two weeks
Secondary Glasgow coma scale To measure level of consciousness Pre intervention and immediate post intervention, through study completion, an average of two weeks
Secondary Riker Sedation-Agitation Scale Arousal/sedation assessment Pre intervention and immediate post intervention, through study completion, an average of two weeks
Secondary Respiratory rate Number of breath cycles per minute Pre intervention and immediate post intervention, through study completion, an average of two weeks
Secondary Minute ventilation The amount of air that enters the lungs per minute. Pre intervention and immediate post intervention, through study completion, an average of two weeks
Secondary Weaning success rate Number of patients weaning from MV post intervention at the end of the study, an average of two weeks
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04053452 - Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome N/A
Recruiting NCT02582853 - sCD163 as a Potential Biomarker in Guillain- Barré Syndrome N/A
Completed NCT00056810 - Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine Phase 2
Completed NCT05104762 - IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients Phase 2/Phase 3
Recruiting NCT05630313 - Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in Brazil
Recruiting NCT03801135 - Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation N/A
Active, not recruiting NCT01655394 - Change of Nerve Conduction Properties in IVIg Dependent Neuropathies N/A
Completed NCT04927598 - Predictors and Prognostic Factors of Gullian Barrie Syndrome Outcome
Completed NCT06334796 - Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology Early Phase 1
Not yet recruiting NCT04092140 - Neuromuscular Ultrasound in Correlation to Neurophysiological Findings
Not yet recruiting NCT04550611 - Mini-pool Intravenous Immunoglobulin (MP-IVIG) in Guillain-Barré Syndrome N/A
Withdrawn NCT03268304 - Feasibility of Two New Software Modules for the Rehabilitation of Patients With Neuromuscular Upper Limb Impairments
Not yet recruiting NCT05701189 - Evaluating Efgartigimod in Patients With Guillain-Barré Syndrome Phase 2
Withdrawn NCT02459808 - Gastrointestinal Transit Time in Patients With Guillain-Barré Syndrome N/A
Completed NCT04752566 - A Study to Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré Syndrome Phase 3
Completed NCT05292690 - An Assistive Powered Wheelchair: Stage 2 Trial
Not yet recruiting NCT06300359 - Prognostic Indicators of Gullian-Barre Syndrome
Completed NCT00575653 - Safety Study of GBS Following Menactra Meningococcal Vaccination N/A
Completed NCT05491096 - Effects of Proprioceptive Neuromuscular Training on Sensory and Motor Function in Guillain Barre Syndrome N/A
Not yet recruiting NCT05114941 - Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome N/A